| NORDEA 2 - EMERGING MARKETS ENHANCED EQUITY FUND BI-USD | RVI EMERGENTES | 49,00% | 66,63% | 42,13% | · |
| VANGUARD EMERGING MARKETS STOCK INDEX GENERAL EUR CAP | RVI EMERGENTES | 49,00% | 59,78% | 35,03% | · |
| VANGUARD EMERGING MARKETS STOCK INDEX INVESTOR EUR CAP | RVI EMERGENTES | 49,00% | 59,78% | 35,03% | · |
| ARTEMIS FUNDS (LUX) - US SMALLER COMPANIES FI GBP DIS | RVI USA SMALL/MID CAP | 48,99% | 40,03% | -3,01% | · |
| LO FUNDS - EMERGING HIGH CONVICTION (USD) M CAP | RVI EMERGENTES | 48,99% | 62,74% | 13,48% | 83,48% |
| NORDEA 2 - EMERGING MARKETS ENHANCED EQUITY FUND BN-USD | RVI EMERGENTES | 48,99% | · | · | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 48,98% | 7,43% | -31,49% | · |
| SPDR S&P U.S. TECHNOLOGY SELECT SECTOR UCITS ETF ACC | TMT | 48,98% | 90,24% | 115,09% | 595,31% |
| WCM GLOBAL EMERGING MARKETS EQUITY I/A (USD) | RVI EMERGENTES | 48,98% | 55,74% | 16,94% | · |
| JPM CHINA A-SHARE OPPORTUNITIES I2 (ACC) EUR | RVI CHINA | 48,97% | 10,37% | -9,83% | · |
